Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Sept.9-22. Deal Watch is supported by deal intelligence from Strategic Transactions.
Allergan PLC staked its ground in the developing non-alcoholic steatohepatitis (NASH) field with the purchase of a pair of...








